-+ 0.00%
-+ 0.00%
-+ 0.00%

Frontage outlines plan to split businesses among Charles River, Tigermed and chairman Song Li

PUBT·11/16/2026 18:08:04
Listen to the news
Frontage outlines plan to split businesses among Charles River, Tigermed and chairman Song Li
  • Frontage’s proposed privatization and subsequent asset breakup, outlined November 16, 2026, follow a November 9 transaction announcement.
  • Charles River Laboratories would acquire the Exton, Pennsylvania-based bioanalysis and drug metabolism and pharmacokinetics operations.
  • Tigermed would take ownership of the China business and operations owned by Acme Bioscience or its subsidiaries.
  • Chairman Song Li would own the remaining operations outside China, including bioanalysis and drug metabolism and pharmacokinetics businesses outside Exton.
  • Completion remains subject to shareholder and regulatory approvals, as well as customary closing conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Frontage Holdings Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: NE98826) on November 16, 2026, and is solely responsible for the information contained therein.